$1.05 Billion is the total value of venBio Partners LLC's 8 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | $715,272,000 | -14.5% | 9,699,925 | 0.0% | 67.97% | -7.9% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $115,793,000 | -8.6% | 3,504,624 | 0.0% | 11.00% | -1.6% | |
| AKRO | AKERO THERAPEUTICS INC | $70,909,000 | +12.4% | 2,444,311 | 0.0% | 6.74% | +21.1% | |
| PHVS | New | PHARVARIS N V | $64,447,000 | – | 2,303,310 | +100.0% | 6.12% | – |
| CMPI | CHECKMATE PHARMACEUTICALS IN | $44,595,000 | -16.8% | 3,673,374 | 0.0% | 4.24% | -10.4% | |
| APLS | APELLIS PHARMACEUTICALS INC | $21,046,000 | -25.0% | 490,471 | 0.0% | 2.00% | -19.2% | |
| MTCR | METACRINE INC | $18,967,000 | -21.1% | 3,059,123 | 0.0% | 1.80% | -15.1% | |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $1,353,000 | -2.9% | 161,897 | -18.7% | 0.13% | +4.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.